ArticleEJHaem2026

Polatuzumab Vedotin Enhances Intratumoral T-Cell Infiltration and Demonstrates Combinatorial Efficacy With Anti-CD20/CD3 Bispecific Antibody in a Syngeneic B-Cell Malignancy Mouse Model.

Mayu Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.